Policy | June 02, 2022
PMBI first time ever crossed Rs. 100 crore sales in May, 2022
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
The product will be launched by NATCO's commercial partner Viatris.
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
Subscribe To Our Newsletter & Stay Updated
